Presentation Details:
Dr. Nina Kim discusses clinical considerations and data for augmenting hepatitis B virus (HBV) treatment, such as in cases of persistent viremia, as well as key clinical considerations for hepatocellular carcinoma (HCC) screening for persons with HIV who have HBV.
Presentation Transcript: